Activating Nature’s Antiviral Shield
Activating Nature’s Antiviral Shield
Activating Nature’s
Antiviral Shield
Lanvira™ is a healthcare company focused on unlocking preventative antiviral powers of Lambda Carrageenan, a natural compound extracted from red seaweed, to create lasting protection for humanity.
Lanvira™ is a healthcare company focused on unlocking preventative antiviral powers of Lambda Carrageenan, a natural compound extracted from red seaweed, to create lasting protection for humanity.
WHAT WE DO
Advancing Science in the Preventative Antivirals Category
Advancing Science in the
Preventative Antivirals Category
We invest in clinical research to unlock the antiviral preventative qualities of lambda carrageenan (L-CGR), a type of naturally occurring sulfated polysaccharide derived from red seaweed, on a broad spectrum of viruses.
The National Cancer Institute, Rutgers University, and McGill University, have produced strong evidence supporting L-CGR's antiviral effectiveness.
Our uncompromising commitment to science combined with strong global IP protection for our discoveries create a solid roadmap towards a healthier future.
WHAT WE DO
Advancing Science in the Preventative Antivirals Category
We invest in clinical research to unlock the antiviral preventative qualities of lambda carrageenan (L-CGR), a type of naturally occurring sulfated polysaccharide derived from red seaweed, on a broad spectrum of viruses.
The National Cancer Institute, Rutgers University, and McGill University, have produced strong evidence supporting L-CGR's antiviral effectiveness.
Our uncompromising commitment to science combined with strong global IP protection for our discoveries create a solid roadmap towards a healthier future.
Universal Preventative Antiviral Treatments
Universal Preventative
Antiviral Treatments
Universal Preventative
Antiviral Treatments
Lambda Carrageenan (L-CRG) is emerging as one of the most promising preventative antiviral solutions effective against a broad spectrum of viruses and viral mutations. Its unique, non-chemical mechanism of action makes it virus agnostic and offers a new proactive approach to viral threats.
Lambda Carrageenan (L-CRG) is emerging as one of the most promising preventative antiviral solutions effective against a broad spectrum of viruses and viral mutations. Its unique, non-chemical mechanism of action makes it virus agnostic and offers a new proactive approach to viral threats.
the problem
Protection Against Viral Mutations
Protection Against Viral Mutations
Viruses, especially RNA viruses like influenza and coronaviruses, are prone to mutations that arise in the replication process. These mutations can alter viral surface proteins, which are key targets for vaccines. As a result, vaccines can become less effective over time, creating an ongoing race between virus evolution and vaccine development.
History of Influenza Pandemics
There have been four influenza pandemics since the turn of the 20th century, occurring in 1918 (H1N1), 1957 (H2N2), 1968 (H3N2), and 2009 (H1N1). This timeline shows the temporal and genetic reassortment relationships among each of the pandemic influenza. Source: The evolution and future of influenza pandemic preparedness.
our solution
our solution
our solution
Carragenix™ Antiviral Gel
Carragenix™ Antiviral Gel
Carragenix™ Antiviral Gel
Carragenix™ is a natural, antiviral gel formulated with Lambda Carrageenan (L-CRG) as its main active ingredient. L-CRG's unique structure, featuring three active sulfate groups, effectively inhibits viral attachment to healthy cells, providing a protective barrier against infection. Carragenix™ can be formulated to meet the specific needs of different markets based on where the gel should be applied.
Our in-vitro testing shows that Carragenix™ is effective across different mutations of influenza, showing promise that it may be able to eliminate the uncertainty caused by mutations.
Carragenix™ is a natural, antiviral gel formulated with Lambda Carrageenan (L-CRG) as its main active ingredient. L-CRG's unique structure, featuring three active sulfate groups, effectively inhibits viral attachment to healthy cells, providing a protective barrier against infection. Carragenix can be formulated to meet the specific needs of different markets based on where the gel should be applied.
Our in-vitro testing shows that Carragenix is effective across different mutations of influenza, showing promise that it may be able to eliminate the uncertainty caused by mutations.
Carragenix™ is a natural, antiviral gel formulated with Lambda Carrageenan (L-CRG) as its main active ingredient. L-CRG's unique structure, featuring three active sulfate groups, effectively inhibits viral attachment to healthy cells, providing a protective barrier against infection. Carragenix™ can be formulated to meet the specific needs of different markets based on where the gel should be applied.
Our in-vitro testing shows that Carragenix™ is effective across different mutations of influenza, showing promise that it may be able to eliminate the uncertainty caused by mutations.
Carragenix™ is a natural, antiviral gel formulated with Lambda Carrageenan (L-CRG) as its main active ingredient. L-CRG's unique structure, featuring three active sulfate groups, effectively inhibits viral attachment to healthy cells, providing a protective barrier against infection. Carragenix™ can be formulated to meet the specific needs of different markets based on where the gel should be applied.
Our in-vitro testing shows that Carragenix™ is effective across different mutations of influenza, showing promise that it may be able to eliminate the uncertainty caused by mutations.
Carragenix™ is a natural, antiviral gel formulated with Lambda Carrageenan (L-CRG) as its main active ingredient. L-CRG's unique structure, featuring three active sulfate groups, effectively inhibits viral attachment to healthy cells, providing a protective barrier against infection. Carragenix™ can be formulated to meet the specific needs of different markets based on where the gel should be applied.
Our in-vitro testing shows that Carragenix™ is effective across different mutations of influenza, showing promise that it may be able to eliminate the uncertainty caused by mutations.
Carragenix™ is a natural, antiviral gel formulated with Lambda Carrageenan (L-CRG) as its main active ingredient. L-CRG's unique structure, featuring three active sulfate groups, effectively inhibits viral attachment to healthy cells, providing a protective barrier against infection. Carragenix™ can be formulated to meet the specific needs of different markets based on where the gel should be applied.
Our in-vitro testing shows that Carragenix™ is effective across different mutations of influenza, showing promise that it may be able to eliminate the uncertainty caused by mutations.
Therapeutic Areas
Therapeutic Areas
Based on our research, Carragenix™ shows strong efficacy against the following categories of both enveloped and non-enveloped viruses
Women’s Health, STIs
Human Respiratory
Animal Respiratory
© 2025 Lanvira™. All rights reserved.
© 2025 Lanvira™. All rights reserved.
© 2025 Lanvira™. All rights reserved.
© 2025 Lanvira™. All rights reserved.